Drug Development Solutions
-
Your Expert Partner In Bringing Biologics To Market
Much more than a CMO, AbbVie is an established biopharmaceutical partner providing comprehensive support at every phase of your mAb’s development to commercial life cycle.
-
Drug Characterization And Release Testing Services
3/27/2024
Learn how leveraging the expertise and flexibility of a partner empowers you to ensure regulatory compliance from the outset, with thorough characterization starting at the earliest stages.
-
Manufacturing GTP And GMP
3/21/2024
Learn how a one-stop solution for your cell therapy needs can help ensure efficiency, cost-effectiveness, and faster patient treatment. Our Draw-to-Thaw® service streamlines the entire process.
-
Oral Solids Made With Intelligent Collaboration
We excel in the manufacture of oral solid dosage forms. For more than 40 years, we’ve been guiding complex compounds securely and efficiently from development through commercial manufacture.
-
Advancing Vaccines From Preclinical Development To Commercial Supply
We are an established leader in advancing vaccines from preclinical development to commercial supply across multiple modalities.
-
CMC Support Services
Over the course of 30+ years we’ve invested in and developed a broad range of expertise, a full suite of lab and analytical services, advanced technology platforms and a world-class facilities network.
-
Develop Lasting Solutions To Analytical Challenges
10/11/2022
KBI’s extensive analytical capabilities help our clients develop lasting solutions to analytical challenges faced during the development of biologics.
-
Where Expertise Meets Simplicity: BD PartnerPath™ Program
8/12/2021
The commercialization of a combination product can be a complex process that involves obtaining the proper data, choosing a drug delivery system, developing a regulatory strategy and conducting clinical trials—all of which can increase development risks and affect your molecule’s time to market.
-
Analytical, Formulation & Stability
2/17/2022
We have experience with monoclonal antibodies, antibody-drug conjugates, and many other molecule types, including highly glycosylated proteins and biosimilars.
-
Customized CMC Solutions
Leverage customizable CMC solutions to address unique developmental challenges and propel your molecule toward IND filing and beyond, ensuring an efficient transition to the next stage of development.